Gliogene is an international consortium of familial brain tumor researchers in the United States, the United Kingdom, Sweden, Denmark and Israel. With Gliogene, we may be able learn more about possible genes related to this disease - and then identify a genetic link among family members of brain tumor patients. Identifying a genetic link may provide information about the disease - information that one day we hope will lead to improved treatment, as well as preventive strategies.

Gliogene is the largest study ever to be conducted on familial gliomas, or primary brain tumors. Researchers aim to screen approximately 15,000 individuals worldwide during the five-year study.